We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Cell Phone Cameras Transmit Medical Data

By Labmedica staff writers
Posted on 12 May 2008
Cell phone cameras can be used to collect medical data from patients and transmit the data to experts located offsite for analysis and diagnosis. More...
This enables patients to receive care when doctors and patients are hundreds or thousands of miles apart.

The system is ideal for developing countries or remote areas lacking advanced medical equipment and trained medical specialists. It can also transmit urgent medical data from battlefields, disaster zones, and other dangerous locations, according to the scientists in the United States and Brazil who developed the technique.

Cell phones are owned by almost three billion users worldwide; roughly half the world's population. Millions of new cell phone users are added each year in Africa and South America and in countries such as India and China. When equipped with cameras, the ubiquitous devices can conceivably be used in remote areas as the eyes and ears of doctors without the need for an on-site visit.

In the latest study, George M. Whitesides, Ph.D., a professor of chemistry at Harvard University (Cambridge, MA, USA) and colleagues in Brazil designed a prototype system that combines cell phone cameras with easy-to-use, paper-based diagnostic tests that undergo color changes when exposed to certain disease markers. The scientists demonstrated the feasibility of the system by using paper test-strips to collect and characterize artificial urine samples, as urine can be easily obtained from patients and contains a wide range of disease markers.

Using a simple cell phone camera, the scientists took pictures of the color-changing test-strips and transmitted them to a remote off-site expert. The expert accurately measured glucose and protein levels--used as hallmarks to diagnose various kidney diseases--from the test-strip image. According to the scientists, similar tests can be conducted on other body fluids, including teardrops and saliva.

"The cellular communications industry is, and will continue to become, a global resource that can be leveraged for detecting disease,” said Dr. George M. Whitesides. Two recent studies by other researchers showed that cell phones can be used to acquire and transmit images of wounds and rashes to off-site locations for diagnosis, he noted.

The new study is published in the May 15, 2008 issue of the American Chemical Society's Analytical Chemistry, a semi-monthly journal.


Related Links:
Harvard University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

Assessing recurrence risk after surgery for early-stage non-small cell lung cancer remains challenging, complicating adjuvant therapy and surveillance decisions. Blood-based molecular residual disease... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.